Related Experiment Video
Updated: Dec 10, 2025
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
The detection of hospitalized patients at risk of testing positive to multi-drug resistant bacteria using MOCA-I, a
Julie Jacques1, Hélène Martin-Huyghe2, Justine Lemtiri-Florek3
1Lille Catholic University, Faculté de Gestion, Economie et Sciences, France; Univ. Lille, CNRS, Centrale Lille, UMR 9189, CRIStAL, Centre de Recherche en Informatique Signal et Automatique de Lille, F-59000 Lille, France.
Background:
Multi-drug resistant (MDR) bacteria are a major health concern. In this retrospective study, a rule-based classification algorithm, MOCA-I (Multi-Objective Classification Algorithm for Imbalanced data) is used to identify hospitalized patients at risk of testing positive for multidrug-resistant (MDR) bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA), before or during their stay.
Methods:
Applied to a data set of 48,945 hospital stays (including known cases of carriage) with up to 16,325 attributes per stay, MOCA-I generated alert rules for risk of carriage or infection. A risk score was then computed from each stay according to the triggered rules.Recall and precision curves were plotted.
Results:
The classification can be focused on specifically detecting high risk of having a positive test, or identifying large numbers of at-risk patients by modulating the risk score cut-off level. For a risk score above 0.85,recall (sensitivity) is 62 % with 69 % precision (confidence) for MDR bacteria, recall is 58 % with 88 % precision for MRSA. In addition, MOCA-I identifies 38 and 21 cases of previously unknown MDR and MRSA respectively.
Conclusions:
MOCA-I generates medically pertinent alert rules. This classification algorithm can be used to detect patients with high risk of testing positive to MDR bacteria (including MRSA). Classification can be modulated by appropriately setting the risk score cut-off level to favor specific detection of small numbers of patients at very high risk or identification of large numbers of patients at risk. MOCA-I can thus contribute to more adapted treatments and preventive measures from admission, depending on the clinical setting or management strategy.
